At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 404 enrolled
Drug / intervention
PCM +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving PTSD Management in Primary Care
In Brief
A Phase 2 clinical trial evaluating PCM and MEU for Stress Disorders, Post-Traumatic. Completed, enrolled 404 participants across 7 sites.
Detailed Summary
The purpose of this study is to conduct a randomized trial of a Post Traumatic Stress Disorder (PTSD) Care Management (PCM) program to detect, treat, and improve PTSD treatment processes and outcomes in patients seeking primary care from FQHCs and evaluate its effectiveness on improving the processes and outcomes of care for PTSD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress Disorders, Post-Traumatic
CountriesUnited States
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedJul 2011
Primary CompletionFeb 2014
Study CompletionMar 2015
TodayJul 2026
First PostedJul 25, 2011
Enrollment StartJun 1, 2010
Primary CompletionFeb 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 14.9 years ago
Interventions
PCMother
Care Manager (CM) intervention
MEUother
The MEU condition consists of only the clinician education and patient screening without written feedback.